Muller & Phipps (India) (BOM:501477) FFO


BOM:501477 Muller & Phipps (India) Ltd BOM:501477
54 GF Score
Price ₹211.85
GF Value ₹280.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Muller & Phipps (India) FFO?

FFO (Funds from operations) only applies to REITs.

BOM:501477
54GF Score
Muller & Phipps (India) Ltd BOM:501477
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Muller & Phipps (India) (BOM:501477) Overvalued in 2026?

Based on GuruFocus' analysis, Muller & Phipps (India) stock appears to be undervalued. The current stock price of ₹211.85 is trading 24.4% below its estimated GF Value™ of ₹280.28. GuruFocus considers Muller & Phipps (India) to be Modestly Undervalued.

Key valuation signals for BOM:501477:

  • FFO:
  • GF Value™: ₹280.28 vs. price of ₹211.85 (24.4% below fair value)
  • GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the BOM:501477 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Muller & Phipps (India) Business Description

Address 204, Madhva Commercial Premises, C-4, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400051
Muller & Phipps (India) Ltd is engaged in the marketing of over-the-counter medical preparations and home care products. The operating segments of the company are Cosmetic/toiletry, Medicated preparation, Food Products, and Others, of which a majority of the revenue is derived from the Medical preparation segment. The company's product portfolio includes medicated dental products, ayurvedic skin ointment, and home care products. Its brand names include Cavisan, Cavidine, and Nixoderm.
54GF Score

Get the complete analysis for BOM:501477

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹211.85
Price
₹280.28
GF Value